Recent Finacing
Recent Raise
Pathalys Pharma is a late-stage clinical biopharmaceutical company in Research Triangle Park developing upacicalcet, a calcimimetic in Phase 3 trials for secondary hyperparathyroidism in hemodialysis patients, preparing NDA.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
